InnoSIGN

Eindhoven, The Netherlands

InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.

$8.1M raised

Mar 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has InnoSIGN raised?

InnoSIGN has raised $8.1M in total funding. The most recent round was Series A. The last funding was announced in March 2022.

Who are InnoSIGN's investors?

InnoSIGN's investors include Casdin Capital, Thuja Capital, Brabant Development, Life Science Angels.

Where is InnoSIGN headquartered?

InnoSIGN is headquartered in Eindhoven, The Netherlands.

What does InnoSIGN do?

InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.

What stage is InnoSIGN at?

InnoSIGN is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 22, 2022.

MLA

"InnoSIGN — Funding & Investors." VCBacked, March 22, 2022, https://www.vcbacked.co/company/innosign. Accessed July 2, 2026.

APA

VCBacked. (2022). InnoSIGN — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/innosign

Wikipedia (cite web)

{{cite web |title=InnoSIGN — Funding & Investors |url=https://www.vcbacked.co/company/innosign |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 22, 2022.